Loading: 100%
PSYCHEMEDICS CORP logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees (as per )no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker PMDno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 171518212427
datesClosing price (adj.)
13.10.201717.37
11.10.201717.95
04.10.201718.09
27.09.201718.59
20.09.201718.22
13.09.201719.52
06.09.201719.87
30.08.201720.95
23.08.201721.51
16.08.201720.60
09.08.201720.61
02.08.201725.65
26.07.201726.20
19.07.201725.80
12.07.201726.53
05.07.201724.93
27.06.201723.52
20.06.201721.93
13.06.201721.71
06.06.201722.34
30.05.201720.06
23.05.201720.89
16.05.201721.66
09.05.201720.20
02.05.201719.00
25.04.201720.31
18.04.201719.55
11.04.201719.51
04.04.201719.81
28.03.201719.41
21.03.201719.47
14.03.201720.22
07.03.201720.73
28.02.201720.93
21.02.201720.22
14.02.201720.44
07.02.201720.29
31.01.201718.45
24.01.201724.67
17.01.201723.64
10.01.201724.02
03.01.201723.47
27.12.201624.29
19.12.201622.05
12.12.201622.68
05.12.201622.24
28.11.201624.46
21.11.201623.84
14.11.201622.89
07.11.201622.71
31.10.201622.81
24.10.201618.62
17.10.201619.06
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
17.37n/a
Market Capitalisation
in million USD
95n/a
Enterprise Value
in million USD
0n/a
Common Shares Outstanding
as per Aug 1, 2017
5,491,553n/a
Preferred Shares Outstanding
as per Aug 1, 2017
n/a
Average Basic Shares Outstanding
TTM
5,465,000n/a
Average Diluted Shares Outstanding
TTM
5,522,250n/a
Index Membership
n/a
Business Summary
Psychemedics Corp provides testing services for the detection of drugs of abuse through the analysis of hair samples. This information is useful to employers for both applicant and employee testing, as well as to physicians and among others.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 0n/a
Receivables 0n/a
Total Current Assets 0n/a
PP&E 0n/a
Total Assets 0n/a
Accounts Payable 0n/a
Current Debt 0n/a
Total Current Liabilities 0n/a
Long-Term Debt 0n/a
Total Liabilities 0n/a
Total Equity 0n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value n/a
Other Ratios
Current Ratio 0.0%n/a
Liabilities to Equity Ratio 0.0%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (12 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenues
17
20
24
25
27
29
27
39
Cost of revenues
7
8
10
11
11
14
14
18
Gross Profit
10
12
14
14
15
15
13
21
General & Administrative
4
4
4
4
4
4
5
5
Marketing & selling
3
3
4
5
5
5
5
5
Research & Development
0
0
1
1
1
1
2
1
Total operating expenses
7
8
9
9
10
10
11
11
Operating Income
3
4
6
5
6
5
1
10
Other expense
0
0
0
0
0
0
0
0
Net income before provision for income taxes
3
4
6
5
6
5
1
10
Provision for / (benefit from) income taxes
1
2
2
2
2
1
0
3
Net income
2
3
3
3
4
3
2
7
Remarks
restated on Mar 9, 2012 n/a
calculated values,
restated on Mar 8, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Mar 7, 2017 n/a
calculated values,
restated on Mar 7, 2017 n/a
calculated values,
restated on Mar 7, 2017 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (34 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
n/a
4
6
3
4
4
3
4
Short term investments
n/a
2
0
0
0
0
0
0
Accounts receivable, net of allowance for doubtful accounts
n/a
4
4
5
4
4
4
6
Prepaid expenses and other current assets
n/a
1
1
1
1
1
1
1
Income tax receivable
n/a
0
1
1
1
2
1
0
Deferred tax assets
n/a
0
0
0
0
0
0
0
Total current assets
n/a
11
12
10
10
11
8
11
Computer software
n/a
1
2
1
2
2
3
0
Office furniture and equipment
n/a
2
2
1
1
1
1
0
Laboratory equipment
n/a
7
8
7
8
13
14
0
Leasehold improvements
n/a
1
1
0
0
2
2
0
Property, Plant and Equipment, Gross, Total
n/a
12
13
9
11
19
20
0
Less - Accumulated depreciation and amortization
n/a
-11
-11
-4
-5
-6
-7
0
Property, Plant and Equipment, Net, Total
n/a
1
2
4
6
13
13
13
Other assets
n/a
0
0
0
1
1
1
1
Total assets
n/a
12
14
14
17
24
22
25
Liabilities and owners' equity
Accounts payable
n/a
1 699833
1 961844
1 669789
1 510550
1 845071
1 747000
1 1363000
Accrued expenses
n/a
1 1302370
1 1321856
1 1413541
2 2447920
1 1351333
1 1198000
2 1988000
Accrued income taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred revenue
n/a
0 16605
0 0
0 0
0 0
0 0
0 0
0 0
Current portion of long-term debt
n/a
0 0
0 0
0 0
0 0
1 1399925
2 1620000
1 1144000
Total current liabilities
n/a
2 2018808
2 2283700
2 2083330
3 2958470
4 3596329
4 3565000
4 4495000
Long-term debt
n/a
0 0
0 0
0 0
0 0
5 4848158
4 4272000
2 2237000
Deferred tax liabilities, long-term
n/a
0 72157
0 482523
1 814619
1 1314221
3 2796666
3 2525000
3 2693000
Total liabilities
n/a
2 2090965
3 2766223
3 2897949
4 4272691
11 11241153
10 10362000
9 9425000
Commitments and contingencies (Note 9)
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Preferred stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Common stock
n/a
0 29387
0 29518
0 29703
0 29910
0 30216
0 30000
0 31000
Accumulated other comprehensive loss
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional paid-in capital
n/a
28 27764992
28 28095946
28 28460764
29 28888712
29 29454023
30 30022000
31 30603000
Less - treasury stock, at cost
n/a
-10 -10059398
-10 -10081789
-10 -10081789
-10 -10081789
-10 -10081789
-10 -10082000
-10 -10082000
Accumulated deficit
n/a
-8 -7987468
-7 -7009046
-7 -7186009
-7 -6559708
-7 -6565894
-8 -8296000
-5 -4945000
Total shareholders' equity
n/a
10 9747513
11 11034629
11 11222669
12 12277125
13 12836556
12 11674000
16 15607000
Total liabilities and shareholders' equity
n/a
12 11838478
14 13800852
14 14120618
17 16549816
24 24077709
22 22036000
25 25032000
Remarks restated on n/a restated on Mar 9, 2012 n/a restated on Mar 8, 2013 n/a restated on Feb 28, 2014 n/a restated on Feb 27, 2015 n/a restated on Feb 26, 2016 n/a restated on Mar 7, 2017 n/a restated on Aug 4, 2017 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (30 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net income
2
3
3
3
4
3
2
7
Depreciation and amortization
0
0
0
1
1
1
2
2
Change in excess tax benefit related to stock
0
0
0
0
0
0
0
0
Deferred income taxes
0
0
0
0
0
1
0
0
Stock compensation expense
0
0
0
0
1
1
1
1
Accounts receivable
0
-1
-1
0
0
0
1
-2
Prepaid expenses, other current assets and income tax receivable
0
0
0
-1
0
-1
1
1
Accounts payable
0
1
0
0
0
0
0
0
Accrued expenses and accrued income taxes
0
0
0
0
0
-1
0
1
Deferred revenue
0
0
0
0
0
0
0
0
Net cash provided by operating activities
2
3
4
3
6
4
5
9
Maturities of short-term investments
0
0
2
0
0
0
0
0
Purchases of short-term investments
-1
-1
0
0
0
0
0
0
Increase in other long-term assets
0
0
0
0
0
0
0
0
Increase in long-term assets; capitalized patent costs
0
0
0
0
0
0
0
0
Purchases of property and equipment and capitalized software development costs
0
-1
-1
-2
-2
-8
-2
-2
Net cash used in investing activities
-1
-2
1
-2
-2
-8
-2
-2
Dividends paid
-3
-3
-3
-3
-3
-3
-3
-3
Proceeds from stock options and tax withholding related to vested shares from employee stock plans
0
0
0
0
0
0
0
0
Acquisition of treasury stock
0
0
0
0
0
0
0
0
Proceeds from equipment financing
0
0
0
0
0
7
1
1
Payments of equipment financing
0
0
0
0
0
-1
-1
-3
Net cash (used in) provided by financing activities
-3
-3
-3
-3
-3
3
-4
-6
Net (decrease) increase in cash and cash equivalents
-2
-1
2
-2
1
0
-1
1
Remarks
restated on Mar 9, 2012 n/a
calculated values,
restated on Mar 8, 2013 n/a
calculated values,
restated on Feb 28, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Mar 7, 2017 n/a
calculated values,
restated on Mar 7, 2017 n/a
calculated values,
restated on Mar 7, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo